Primary dysmenorrhoea. Primary dysmenorrhoea
Conditions
Interventions
Intervention 1: Group B mefenamic acid capsules of 250 mg every 6 hours for 4 days of menstruation is given. Intervention 2: Group C placebo capsules for 4 days is menstruation. Intervention 3: A grou
Treatment - Drugs
Group B mefenamic acid capsules of 250 mg every 6 hours for 4 days of menstruation is given.
Group C placebo capsules for 4 days is menstruation.
A group of cimetidine 300 mg every 6 hours for 4 days of menstruation is given.
Sponsors
Semnan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 22 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age 22-18 years old; one year of regular menstrual cycle; the first three days of menstruation; menstrual complaints of pain; pain cycle so that more medication may be needed. Exclusion criteria: lack of sufficient cooperation; BMI more than 26; history of gastrointestinal disease, such as I BS; urological disease (repetition burning urination); Endometriosis; Epilepsy; genital system disorders such as infectious disease; previous abdominal surgery; a history full term pregnancy; - a history of sensitivity to cimetidine; drugs interaction with cimetidine for example: Warfarin - phenytoin - Inderal - nifedipine. Diazepam and antidepressants - Lidocaine - theophylline - metronidazole; use of other drugs to reduce the pain of dysmenorrhea.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Analgesia. Timepoint: For 6 months after intervention. Method of measurement: Numeric Rating Pain Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactForozeshfard Mohammad
Semnan University of Medical Sciences
Outcome results
None listed